Foghorn Therapeutics
Biotechnology, 500 Technology Sq Ste 700, Cambridge, Massachusetts, 02139, United States, 51-200 Employees
Phone Number: 16*********
Who is FOGHORN THERAPEUTICS
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untap...
Read More
- Headquarters: 500 Technology Sq Ste 700, Cambridge, Massachusetts, 02139, United States
- Date Founded: 2016
- Employees: 51-200
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Karin Hellsvik
Industry: Biotechnology
SIC Code: 2836 | NAICS Code: 541714 | Show More
Does something look wrong? Fix it. | View contact records from FOGHORN THERAPEUTICS
Foghorn Therapeutics Org Chart and Mapping
Karin Hellsvik
Vice President, Corporate Affairs, Investor Communications, Chief of Staff to the CEO
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Foghorn Therapeutics
Answer: Foghorn Therapeutics's headquarters are located at 500 Technology Sq Ste 700, Cambridge, Massachusetts, 02139, United States
Answer: Foghorn Therapeutics's phone number is 16*********
Answer: Foghorn Therapeutics's official website is https://foghorntx.com
Answer: Foghorn Therapeutics's revenue is $1 Million to $5 Million
Answer: Foghorn Therapeutics's SIC: 2836
Answer: Foghorn Therapeutics's NAICS: 541714
Answer: Foghorn Therapeutics has 51-200 employees
Answer: Foghorn Therapeutics is in Biotechnology
Answer: Foghorn Therapeutics contact info: Phone number: 16********* Website: https://foghorntx.com
Answer: Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
CEO at Foghorn Therapeutics
Karin Hellsvik
Vice President, Corporate Affairs, Investor Communications, Chief of Staff to the CEO
Sign in to CIENCE GO Data to uncover contact details
Free credits every month